Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William V Bobo

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Journal of Child and Adolescent Psychopharmacology|September 5, 2024
Not Too Rare to Matter: The Incidence of Neuroleptic Malignant Syndrome in Children and Adolescents Treated with AntipsychoticsWilliam V Bobo
Expert Review of Clinical Pharmacology|January 1, 2013
Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adultsWilliam V Bobo
Evidence-Based Mental Health|March 7, 2015
More evidence of an association between antipsychotic drugs and the risk of diabetes in children and adolescents: a population-based studyWilliam V Bobo
Mayo Clinic Proceedings|September 11, 2017
The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice UpdateWilliam V Bobo
Journal of Child and Adolescent Psychopharmacology|November 17, 2025
How Much Is Too Much? Escalating Psychotropic Class Polypharmacy, Diabetes Risk, and Clinical Complexity in Stimulant New UsersWilliam V Bobo, Walter Carr
Military Medicine|October 5, 2002
Handling human remains following the terrorist attack on the Pentagon: experiences of 10 uniformed health care workersRichard T Keller, William V Bobo
The American Journal of Emergency Medicine|January 25, 2005
Commentary on: Severe manifestations of coricidin intoxicationWilliam V Bobo, Robert B Fulton
Expert Review of Neurotherapeutics|October 28, 2010
Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorderWilliam V Bobo, Richard C Shelton
Neuropsychiatric Disease and Treatment|July 11, 2009
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issuesWilliam V Bobo, Richard C Shelton
Primary Care Companion to the Journal of Clinical Psychiatry|May 22, 2004
Potential Association Between Risperidone and Cerebrovascular EventsWilliam V. Bobo, Kenneth F. More
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Journal of Child and Adolescent Psychopharmacology|September 5, 2024
Not Too Rare to Matter: The Incidence of Neuroleptic Malignant Syndrome in Children and Adolescents Treated with AntipsychoticsWilliam V Bobo
Expert Review of Clinical Pharmacology|January 1, 2013
Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adultsWilliam V Bobo
Evidence-Based Mental Health|March 7, 2015
More evidence of an association between antipsychotic drugs and the risk of diabetes in children and adolescents: a population-based studyWilliam V Bobo
Mayo Clinic Proceedings|September 11, 2017
The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice UpdateWilliam V Bobo
Journal of Child and Adolescent Psychopharmacology|November 17, 2025
How Much Is Too Much? Escalating Psychotropic Class Polypharmacy, Diabetes Risk, and Clinical Complexity in Stimulant New UsersWilliam V Bobo, Walter Carr
Military Medicine|October 5, 2002
Handling human remains following the terrorist attack on the Pentagon: experiences of 10 uniformed health care workersRichard T Keller, William V Bobo
The American Journal of Emergency Medicine|January 25, 2005
Commentary on: Severe manifestations of coricidin intoxicationWilliam V Bobo, Robert B Fulton
Expert Review of Neurotherapeutics|October 28, 2010
Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorderWilliam V Bobo, Richard C Shelton
Neuropsychiatric Disease and Treatment|July 11, 2009
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issuesWilliam V Bobo, Richard C Shelton
Primary Care Companion to the Journal of Clinical Psychiatry|May 22, 2004
Potential Association Between Risperidone and Cerebrovascular EventsWilliam V. Bobo, Kenneth F. More
Pageof 18